Contact number:
400 007 5658
-
To provide Chinese and foreign patients with secure and affordable drugs.
Research, development (R&D) and production of high-end generic drugs, which have its quality and efficacy in consistency with that of the original ones as well as innovative preparations with clinical advantages, so as to provide Chinese and foreign patients with secure and affordable drugs.
-
To provide Chinese and foreign patients with secure and affordable drugs.
Research, development (R&D) and production of high-end generic drugs, which have its quality and efficacy in consistency with that of the original ones as well as innovative preparations with clinical advantages, so as to provide Chinese and foreign patients with secure and affordable drugs.
-
To provide Chinese and foreign patients with secure and affordable drugs.
Research, development (R&D) and production of high-end generic drugs, which have its quality and efficacy in consistency with that of the original ones as well as innovative preparations with clinical advantages, so as to provide Chinese and foreign patients with secure and affordable drugs.
01
Corporate Culture
Corporate Culture
Corporate Culture
Who Are We?
Anbison is a pharmaceutical company invested and operated by a number of pharmaceutical professionals at home and abroad; established in scientific development, manufacture and commercialization of pharmaceutical preparations. Anbison is dedicated to research, development (R&D) and production of high-end generic drugs which have its quality and efficacy in consistency with that of the original ones as well as improved new drug with clinical advantages; aimed at both domestic and oversea markets of pharmaceutical preparations; specialized in process scale up and manufacture of complex products; focused on quality assurance and production efficiency so as to provide patients with high-quality and affordable therapeutic drugs.
15+ Year
Anbison has been working on drug preparation research and development for 14 years
50+ ANDA
50 plus products have been filed, 30 plus products have been approved
20000+ ㎡
Manufacture facilities for multi-dosage form, modified release and long-lasting injection production
Product Center
Product information is for medical professional’s reference only. These products may not have been approved and/or licensed for listing in all countries with access to this website.
Product Pipeline
With the R&D and manufacture of controlled-release drug products as the core business, Anbison focuses on development of high-end controlled-release dosage forms and finished dosage forms that are inherently difficult to manufacture. Meanwhile, we are actively expanding to 505b(2) drugs and complex long-acting injectables.
Business Partner
We maintain close cooperation with our industrial chain for mutual growth and development.
-
R&D
-
Clinical Research
-
Manufacture
-
Commercialization
-
Industry Collaboration
-
-
Address: No. 18 Qujing Road, Xuhui District, Shanghai, China
Tel:+86 21 5497 349724 hours hotline:400 007 5658